(Q26828479)

Marcio H Malogolowkin

8

object named as

Marcio Malogolowkin

1 reference

author name string

Dolores López-Terrada

1

1 reference

Rita Alaggio

2

1 reference

Maria T de Dávila

3

1 reference

Eiso Hiyama

5

1 reference

Howard Katzenstein

6

1 reference

Ivo Leuschner

7

1 reference

Rebecka Meyers

9

1 reference

Sarangarajan Ranganathan

10

1 reference

Yukichi Tanaka

11

1 reference

Gail Tomlinson

12

1 reference

Monique Fabrè

13

1 reference

Arthur Zimmermann

14

1 reference

Milton J Finegold

15

1 reference

language of work or name

1 reference

March 2014

1 reference

1 reference

27

1 reference

issue

3

1 reference

page(s)

472-91

1 reference

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Primary hepatic tumors of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Teratoid hepatoblastoma. The nosologic dilemma of solid embryonic neoplasms of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Liver neoplasia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Risk factors for the rising rates of primary liver cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Critical review of controversial issues in the management of advanced pediatric liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Third report of t(19q)(13.4) in mesenchymal hamartoma of liver with comments on link to embryonal sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Blocking the hedgehog pathway inhibits hepatoblastoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Drug resistance in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Epidemiology of primary hepatic malignancies in U.S. children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

Small cell undifferentiated histology in hepatoblastoma may be unfavorable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Hepatic tumors in children

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Stages of normal and aberrant intrahepatic bile duct development in a mixed hepatoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with cushing syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Hepatoblastoma: The Prognostic Significance of Histologic Type

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Not all hemangiomas are benign--epithelioid hemangioendothelioma: an aggressive vascular lesion in children

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

The occurrence of liver growth factor in hepatoblastoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.80

7 January 2021

10.1038/MODPATHOL.2013.80

Identifiers

DOI

0 references

Dimensions Publication ID

1031527752

0 references

PubMed publication ID

24008558

1 reference